StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Oncotelic Therapeutics's price to book ratio was 0.0× on Oct 19, 2026, against 4.8× a year earlier. Over the last 5 years it ranged from 0.0× to 13.1×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−3.8
2025Dec 31, 20253.9×+2.2
2024Dec 31, 20241.6×+0.3
2023Dec 29, 20231.3×+0.5
2022Dec 30, 20220.8×−7.1
2021Dec 31, 20217.9×+6.6
2020Dec 31, 20201.3×−1.6
2019Dec 31, 20193.0×+2.3
2018Jan 31, 20180.7×+0.2
2017Dec 29, 20170.4×+0.3
2016Dec 30, 20160.1×−0.0
2015Dec 31, 20150.1×−0.1
2014Dec 31, 20140.2×+0.0
2013Dec 31, 20130.2×−0.1
2012Dec 31, 20120.3×+0.0
2011Dec 30, 20110.3×–

More Oncotelic Therapeutics figures

See a number that looks wrong?